Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Sonoma Pharmaceuticals stock
Learn how to easily invest in Sonoma Pharmaceuticals stock.
Sonoma Pharmaceuticals Inc is a drug manufacturers-specialty & generic business based in the US. Sonoma Pharmaceuticals shares (SNOA) are listed on the NASDAQ and all prices are listed in US Dollars. Sonoma Pharmaceuticals employs 12 staff and has a trailing 12-month revenue of around $12.9 million.
How to buy shares in Sonoma Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – SNOA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Sonoma Pharmaceuticals stock price (NASDAQ: SNOA)Use our graph to track the performance of SNOA stocks over time.
Sonoma Pharmaceuticals shares at a glance
|Latest market close||$2.13|
|52-week range||$2.17 - $8.76|
|50-day moving average||$3.01|
|200-day moving average||$3.40|
|Wall St. target price||$9.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.42|
Buy Sonoma Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Sonoma Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Sonoma Pharmaceuticals price performance over time
|1 week (2022-09-23)||-2.29%|
|1 month (2022-09-01)||-22.22%|
|3 months (2022-07-01)||-27.30%|
|6 months (2022-04-01)||-41.96%|
|1 year (2021-09-27)||N/A|
|2 years (2020-10-01)||-74.82%|
|3 years (2019-10-01)||5.76|
|5 years (2017-09-29)||5.22|
Sonoma Pharmaceuticals financials
|Revenue TTM||$12.9 million|
|Gross profit TTM||$4 million|
|Return on assets TTM||-23.33%|
|Return on equity TTM||-77.5%|
|Market capitalisation||$6.8 million|
TTM: trailing 12 months
Sonoma Pharmaceuticals share dividends
We're not expecting Sonoma Pharmaceuticals to pay a dividend over the next 12 months.
Have Sonoma Pharmaceuticals's shares ever split?
Sonoma Pharmaceuticals's shares were split on a 1:9 basis on 20 June 2019. So if you had owned 9 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Sonoma Pharmaceuticals shares – just the quantity. However, indirectly, the new 800% higher share price could have impacted the market appetite for Sonoma Pharmaceuticals shares which in turn could have impacted Sonoma Pharmaceuticals's share price.
Sonoma Pharmaceuticals share price volatility
Over the last 12 months, Sonoma Pharmaceuticals's shares have ranged in value from as little as $2.17 up to $8.76. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sonoma Pharmaceuticals's is 0.9505. This would suggest that Sonoma Pharmaceuticals's shares are less volatile than average (for this exchange).
Sonoma Pharmaceuticals overview
Sonoma Pharmaceuticals, Inc. , develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a HOCl-based topical prescription product indicated to promote efficient healing through the management of new and old scars; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis. It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a wide range of pathogens, as well as antibiotic-resistant strains that slow the natural healing of wounds. In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Microdacyn60 oral care solution for the treatment of mouth and throat infections; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; Pediacyn atopic dermatitis hydrogel; Ocucyn eyelid and eyelash cleanser; Gramaderm for the treatment of topical mild to moderate acne; Nanocyn, a hospital-grade disinfectant; and Sinudox for nasal irrigation. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc.
Frequently asked questionsWhat percentage of Sonoma Pharmaceuticals is owned by insiders or institutions?
Currently 0.386% of Sonoma Pharmaceuticals shares are held by insiders and 5.962% by institutions. How many people work for Sonoma Pharmaceuticals?
Latest data suggests 12 work at Sonoma Pharmaceuticals. When does the fiscal year end for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals's fiscal year ends in March. Where is Sonoma Pharmaceuticals based?
Sonoma Pharmaceuticals's address is: 645 Molly Lane, Woodstock, GA, United States, 30189 What is Sonoma Pharmaceuticals's ISIN number?
Sonoma Pharmaceuticals's international securities identification number is: US83558L2043 What is Sonoma Pharmaceuticals's CUSIP number?
Sonoma Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 67575P108
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert